Epidemiology


Etiology


  • Atherosclerosis (∼ 90% of cases): occurs more often in men > 50 years of age; increased risk in smokers
  • Fibromuscular dysplasia (∼ 10% of cases): mostly affects women < 50 years of age

Pathophysiology


  • Narrowing of one or both renal arteries → obstruction of renal blood flow → ischemia → renin release and activation of the renin-angiotensin-aldosterone system → hyperreninemic hyperaldosteronism (increased renin → increased angiotensin → increased aldosterone) → increased sodium retention and peripheral vascular resistance → renovascular hypertension (secondary hypertension)
  • Prolonged renal hypoperfusion → chronic stimulation of the juxtaglomerular apparatus to secrete renin → hyperplasia of the juxtaglomerular apparatus
  • No improvement in renal blood flow → ischemic renal injury → renal insufficiency and progressive renal atrophy (unilateral or bilateral depending on laterality of RAS)

Clinical features


  • Family history of hypertension is often absent.
  • Hypertension: severe (i.e., resistant to therapy) and/or early-onset (i.e, hypertension in individuals < 30 years of age)
  • Abdominal bruit heard over the flank or epigastrium: present during both systole and diastole
  • Flash pulmonary edema
  • Features of atherosclerosis in other parts of the body (e.g., peripheral artery disease, coronary artery disease, carotid stenosis)

Diagnostics


  • New-onset or worsening of renal dysfunction (↑ serum creatinine) after initiating ACE inhibitors or ARBs
    • ACE inhibitors and ARBs can induce or worsen renal insufficiency, particularly in patients with severe bilateral renal artery stenosis or high-grade unilateral stenosis.
  • Unexplained renal atrophy or asymmetry of > 1.5 cm between the kidneys
  • Unexplained acute pulmonary edema
  • DDx: Fibromuscular dysplasia

Treatment